APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $323,340 | -68.8% | 8,500 | -45.9% | 0.00% | -77.8% |
| Q1 2023 | $1,035,572 | -94.2% | 15,700 | -95.4% | 0.01% | -91.0% |
| Q4 2022 | $17,839,950 | -7.4% | 345,000 | +22.3% | 0.10% | +11.1% |
| Q3 2022 | $19,261,000 | +35.7% | 282,000 | -10.2% | 0.09% | +76.5% |
| Q2 2022 | $14,199,000 | +4.2% | 314,000 | +17.1% | 0.05% | +8.5% |
| Q1 2022 | $13,622,000 | +90.9% | 268,100 | +23.8% | 0.05% | +88.0% |
| Q3 2021 | $7,136,000 | +3.4% | 216,500 | +98.3% | 0.02% | -16.7% |
| Q2 2021 | $6,901,000 | – | 109,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |